The development of new antileukotriene drugs: specific leukotriene D4 antagonists and 5-lipoxygenase inhibitors
- PMID: 2560345
- DOI: 10.1007/978-1-4684-5700-1_4
The development of new antileukotriene drugs: specific leukotriene D4 antagonists and 5-lipoxygenase inhibitors
Similar articles
-
The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice.Agents Actions. 1987 Aug;21(3-4):316-9. doi: 10.1007/BF01966502. Agents Actions. 1987. PMID: 3687587 No abstract available.
-
Wy-45,911: a novel leukotriene antagonist with lipoxygenase inhibitory activity.Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:536-9. Adv Prostaglandin Thromboxane Leukot Res. 1987. PMID: 2959109 No abstract available.
-
Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists.J Med Chem. 1987 Jan;30(1):96-104. doi: 10.1021/jm00384a017. J Med Chem. 1987. PMID: 3806607
-
The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses.Ann N Y Acad Sci. 1988;524:307-20. doi: 10.1111/j.1749-6632.1988.tb38554.x. Ann N Y Acad Sci. 1988. PMID: 2837965 Review.
-
The use of leukotriene D4 receptor antagonists and 5-lipoxygenase inhibitors to define a role for leukotrienes in allergic reactions.Adv Prostaglandin Thromboxane Leukot Res. 1989;19:507-10. Adv Prostaglandin Thromboxane Leukot Res. 1989. PMID: 2546393 Review. No abstract available.